Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Impact of Hospital Volume on Outcomes of Septal Myectomy for Hypertrophic Cardiomyopathy.

Authors:
Kimberly A Holst Hartzell V Schaff Nicholas G Smedira Elizabeth B Habermann Courtney N Day Vinay Badhwar Hiroo Takayama Patrick M McCarthy Joseph A Dearani

Ann Thorac Surg 2022 Jun 30. Epub 2022 Jun 30.

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.

Background: Left ventricular outflow tract obstruction is common among symptomatic patients with hypertrophic cardiomyopathy, yet septal reduction by surgical myectomy (septal myectomy [SM]) is performed infrequently in many centers. This study examined the possible relationship between institutional case volume and early outcomes of SM.

Methods: The Society of Thoracic Surgeons Adult Cardiac Surgery Database was queried for patients with hypertrophic cardiomyopathy who underwent SM from January 2012 to December 2019. The study defined center case volume categories as <1, 1 to 4.99, 5 to 9.99, and ≥10 cases performed on average per year.

Results: The study population included 5935 patients at 481 centers with 933 surgeons. The range of average center volume was <1 to 138 cases per year. Overall early mortality was 2.6%, ventricular septal defect (VSD) occurred in 1.9%, and complete heart block occurred in 9.0%. Concomitant mitral valve (MV) repair was performed in 28.7%, and MV replacement was performed in 17.1%. In multivariable analysis, the lowest annual case volume (average <1 case/y) was consistently associated with greater early mortality (odds ratio [OR], 5.4; CI, 3.0-9.9; P < .001), greater risk of VSD (OR, 9.3; CI ,4.2-20.4; P < .001), increased incidence of complete heart block (OR, 2.0; CI, 1.5-2.7; P < .001), and a higher likelihood of MV replacement (OR, 9.4; CI, 7.5-11.8; P < .001).

Conclusions: Volume of SM cases varies widely among institutions reporting to the Society of Thoracic Surgeons Adult Cardiac Surgery Database. There appears to be an important association between surgical experience, as reflected by institutional case volume, and early outcomes, including mortality, as well as the occurrence of VSD, heart block, and MV replacement.

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.athoracsur.2022.05.062DOI Listing
June 2022

Publication Analysis

Top Keywords

hypertrophic cardiomyopathy
12
case volume
8
patients hypertrophic
8
volume early
4
myectomy [sm]
4
surgery database
4
cardiomyopathy septal
4
cardiac surgery
4
septal reduction
4
adult cardiac
4
reduction surgical
4
surgical myectomy
4
myectomy septal
4
septal myectomy
4
surgeons adult
4
thoracic surgeons
4
examined relationship
4
[sm] performed
4
symptomatic patients
4
relationship institutional
4

Keyword Occurance

Similar Publications

Radiofrequency ablation of hypertrophic obstructive cardiomyopathy - a potential method for clinical application.

Authors:
Huasheng Lv Yongqiang Fan Meidina Yeerken Liang Gao Baopeng Tang Yanmei Lu

Int J Cardiol 2022 Aug 3. Epub 2022 Aug 3.

Department of Cardiac Pacing and Electrophysiology, The First Affiliated Hospital of Xinjiang Medical University, China; Xinjiang Key Laboratory of Cardiac Electrophysiology and Remodeling, The First Affiliated Hospital of Xinjiang Medical University, China. Electronic address:

View Article and Full-Text PDF
August 2022
Similar Publications

Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease.

Authors:
Francesca Graziani Rosa Lillo Elena Biagini Giuseppe Limongelli Camillo Autore Maurizio Pieroni Chiara Lanzillo Leonardo Calò Maria Beatrice Musumeci Gessica Ingrasciotta Matteo Minnucci Raffaello Ditaranto Alessandra Milazzo Chiara Zocchi Marta Rubino Gaetano Antonio Lanza Iacopo Olivotto Filippo Crea

Int J Cardiol 2022 Aug 2. Epub 2022 Aug 2.

Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Catholic University of the Sacred Heart, Rome, Italy.

Background: Little is known about prevalence and predictors of myocardial infarction with non-obstructive coronary arteries (MINOCA) in Fabry disease (FD) and hypertrophic cardiomyopathy (HCM). We assessed and compared the prevalence and predictors of MINOCA in a large cohort of HCM and FD patients.

Methods: In this multicenter, retrospective study we enrolled 2870 adult patients with HCM and 267 with FD. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

[Analysis of phenotype and MYH7 gene variant in a family of patients with hypertrophic cardiomyopathy].

Authors:
Xueli Zhao Bo Wang Xiaoli Zhu Qianli Yang Ying Liu Hong Shao Lei Zuo Yun Luo Yue Wang Liwen Liu

Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2022 Aug;39(8):873-876

Hypertrophic Cardiomyopathy Center of Xijing Hospital of Air Force Medical University, Multi Disciplinary Consultation Center of Hypertrophic Cardiomyopathy of Shaanxi Province, Department of Ultrasonography, Xijing Hospital of Air Force Medical University, Xi'an, Shaanxi 710032, China.

Objective: To analyze the clinical phenotype and MYH7 gene variant in a Chinese pedigree affected with hypertrophic cardiomyopathy (HCM).

Methods: The proband was screened for variant of 96 cardiomyopathy-associated genes by exonic amplification and high-throughput sequencing. Candidate variant was verified by Sanger sequencing among 300 healthy controls as well as family members of the proband. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Major Clinical Issues in Hypertrophic Cardiomyopathy.

Authors:
Hyun-Jung Lee Jihoon Kim Sung-A Chang Yong-Jin Kim Hyung-Kwan Kim Sang Chol Lee

Korean Circ J 2022 Aug;52(8):563-575

Division of Cardiology, Department of Medicine, Samsung Medical Center, Heart Vascular Stroke Institute, Sungkyunkwan University School of Medicine, Seoul, Korea.

Hypertrophic cardiomyopathy (HCM) is one of the most common inheritable cardiomyopathies. Contemporary management strategies, including the advent of implantable cardioverter-defibrillators and effective anticoagulation, have substantially improved the clinical course of HCM patients; however, the disease burden of HCM is still high in Korea. Sudden cardiac death (SCD), atrial fibrillation and thromboembolic risk, dynamic left ventricular outflow tract (LVOT) obstruction, and heart failure (HF) progression remain important issues in HCM. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Editorial: Advanced echocardiographic techniques in structural heart intervention.

Authors:
Randolph H L Wong Yiting Fan Masaki Izumo Alex P W Lee

Front Cardiovasc Med 2022 18;9:970515. Epub 2022 Jul 18.

Division of Cardiology, Department of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.

View Article and Full-Text PDF
July 2022
Similar Publications
}